These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2629861)

  • 1. Sonicated echocardiographic contrast agents: reproducibility studies.
    Feinstein SB; Keller MW; Kerber RE; Vandenberg B; Hoyte J; Kutruff C; Bingle J; Fraker TD; Chappell R; Welsh AH
    J Am Soc Echocardiogr; 1989; 2(2):125-31. PubMed ID: 2629861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sonicated X-ray contrast agents for quantitative myocardial contrast echocardiography--a critical approach.
    Mayer IV; Lazarov MP; Utzinger U; Freiburghaus AU; Hess OM
    Heart Vessels; 1995; 10(2):96-105. PubMed ID: 7782270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Automated production and analysis of echo contrast agents.
    Keller MW; Feinstein SB; Briller RA; Powsner SM
    J Ultrasound Med; 1986 Sep; 5(9):493-8. PubMed ID: 3761412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visually discernible myocardial echocardiographic contrast after intravenous injection of sonicated dextrose albumin microbubbles containing high molecular weight, less soluble gases.
    Porter TR; Xie F
    J Am Coll Cardiol; 1995 Feb; 25(2):509-15. PubMed ID: 7829807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Italian Society of Cardiovascular Echography (SIEC) Consensus Conference on the state of the art of contrast echocardiography.
    Ital Heart J; 2004 Apr; 5(4):309-34. PubMed ID: 15185894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymeric microballoons as ultrasound contrast agents. Physical and ultrasonic properties compared with sonicated albumin.
    Schneider M; Bussat P; Barrau MB; Arditi M; Yan F; Hybl E
    Invest Radiol; 1992 Feb; 27(2):134-9. PubMed ID: 1376304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microbubble dynamics visualized in the intact capillary circulation.
    Feinstein SB; Shah PM; Bing RJ; Meerbaum S; Corday E; Chang BL; Santillan G; Fujibayashi Y
    J Am Coll Cardiol; 1984 Sep; 4(3):595-600. PubMed ID: 6470341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myocardial perfusion imaging by contrast echocardiography with use of intracoronary sonicated albumin in humans.
    Reisner SA; Ong LS; Lichtenberg GS; Amico AF; Shapiro JR; Allen MN; Meltzer RS
    J Am Coll Cardiol; 1989 Sep; 14(3):660-5. PubMed ID: 2768714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-speed optical observations of contrast agent destruction.
    Bouakaz A; Versluis M; de Jong N
    Ultrasound Med Biol; 2005 Mar; 31(3):391-9. PubMed ID: 15749563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimization of the size distribution and myocardial contrast effect of perfluorocarbon-filled albumin microbubbles by lyophilization under continuous negative pressure.
    Chen S; Wang Z; Zhou YT; Grayburn PA
    J Am Soc Echocardiogr; 2000 Aug; 13(8):748-53. PubMed ID: 10936818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two-dimensional contrast echocardiography. I. In vitro development and quantitative analysis of echo contrast agents.
    Feinstein SB; Ten Cate FJ; Zwehl W; Ong K; Maurer G; Tei C; Shah PM; Meerbaum S; Corday E
    J Am Coll Cardiol; 1984 Jan; 3(1):14-20. PubMed ID: 6690542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful left ventricular opacification following peripheral venous injection of sonicated contrast agent: an experimental evaluation.
    Keller MW; Feinstein SB; Watson DD
    Am Heart J; 1987 Sep; 114(3):570-5. PubMed ID: 3307360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitation of echo-contrast effects.
    Powsner SM; Keller MW; Saniie J; Feinstein SB
    Am J Physiol Imaging; 1986; 1(3):124-8. PubMed ID: 3451757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The behavior of sonicated albumin microbubbles within the microcirculation: a basis for their use during myocardial contrast echocardiography.
    Keller MW; Segal SS; Kaul S; Duling B
    Circ Res; 1989 Aug; 65(2):458-67. PubMed ID: 2752551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions between microbubbles and ultrasound: in vitro and in vivo observations.
    Wei K; Skyba DM; Firschke C; Jayaweera AR; Lindner JR; Kaul S
    J Am Coll Cardiol; 1997 Apr; 29(5):1081-8. PubMed ID: 9120163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of individual microbubbles of ultrasound contrast agents: imaging of free-floating and targeted bubbles.
    Klibanov AL; Rasche PT; Hughes MS; Wojdyla JK; Galen KP; Wible JH; Brandenburger GH
    Invest Radiol; 2004 Mar; 39(3):187-95. PubMed ID: 15076011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generating precision microbubbles for use as an echocardiographic contrast agent.
    Meltzer RS; Klig V; Teichholz LE
    J Am Coll Cardiol; 1985 Apr; 5(4):978-82. PubMed ID: 3973301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Experimental study on efficacy of myocardial opacification owing to difference of echocardiographic contrast agents].
    Suzuki M; Yamaguchi T
    Nihon Rinsho; 1998 Apr; 56(4):909-13. PubMed ID: 9577607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The experimental investigation of ultrasonic properties for a sonicated contrast agent and its application in biomedicine.
    Zhang D; Gong XF; Liu JH; Shao LZ; Li XR; Zhang QL
    Ultrasound Med Biol; 2000 Feb; 26(2):347-51. PubMed ID: 10722925
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.